Physician profile
Nowrin Haque
NPI 1750888392
$2,327.02
in general payments reported to CMS, 2019-2025
13 companies · $815 in 2025
The $815 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.27 · 2022: $18.89 · 2024: $1,457 · 2025: $815.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,080 · Education: $161 · Travel and Lodging: $30.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,079.52 |
| Education | $161.49 |
| Travel and Lodging | $30.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $626.38 | 2022-2025 | Avvigo Guidance System, Rotapro |
| Abiomed | $446.72 | 2024-2025 | Impella |
| Medtronic, INC. | $340.77 | 2021-2024 | Onyx Frontier, Symplicity G3, Resolute Onyx |
| Shockwave Medical, INC | $248.20 | 2025 | |
| Irhythm Technologies, INC. | $232.95 | 2024 | Zio Monitor, Zio Xt Patch |
| Stryker Corporation | $126.60 | 2025 | Flowtriever |
| Inari Medical, INC. | $104.33 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.28 | 2025 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $45.46 | 2025 | Opsynvi, Uptravi |
| Merck Sharp & Dohme LLC | $33.45 | 2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.61 | 2021 | |
| Cvrx, INC. | $22.25 | 2025 | Barostim Neo System |
| Bridgebio Pharma, INC. | $21.02 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nowrin Haque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.